Disc Disease Clinical Trial
Official title:
Functional Outcome After Lumbar Epidural Steroid Injection
prospectively validate a fibronectin-aggrecan complex as a biomarker for response to ESI for radiculopathy with HNP
We will measure levels of the protein complex in the epidural space of patients undergoing lumbar ESI for radiculopathy with HNP. We assess functional outcomes at baseline and after treatment with the Medical Outcomes Study Short Form-36 instrument (SF-36). Our hypothesis was that the complex is present in patients with clinically significant functional improvement after ESI. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05971329 -
Pilot Study of ZetaFuseā¢ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
|
Early Phase 1 | |
Active, not recruiting |
NCT04559295 -
Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs
|
Phase 2/Phase 3 | |
Recruiting |
NCT03644407 -
Galeazzi Spine Surgery RegistryGaleazzi Spine Registry: Prospective Study for Clinical Monitoring
|
||
Withdrawn |
NCT02827981 -
Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease
|
N/A | |
Completed |
NCT01499641 -
Epidural Steroid Following Discectomy for Herniated Disc Reduces Morbidity
|
N/A | |
Not yet recruiting |
NCT06367855 -
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF : Double Blinded, Randomized Control Trial
|
Phase 4 | |
Recruiting |
NCT06352710 -
Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment - a Collaborative Observational Research Project
|
||
Recruiting |
NCT04621799 -
Fibrin for Chronic Multi-level Discogenic Low Back Pain
|
Phase 2/Phase 3 |